OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Thomas Montine

1 Projects | 1 Researchers | $468,500 Invested

2020

Stanford University

Thomas Montine, MD, PhD

Blood-based immune biomarkers for Alzheimer's disease diagnosis and its early detection

  • Funding Amount: $468,500
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Systemic Inflammation
  • Status: Closed